- Home
- ATXS vs RWAY Comparison
ATXS vs RWAY Comparison
Compare ATXS & RWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXS
- RWAY
- Stock Information
- Founded
- ATXS 2008
- RWAY 2015
- Country
- ATXS United States
- RWAY United States
- Employees
- ATXS N/A
- RWAY N/A
- Industry
- ATXS Biotechnology: Pharmaceutical Preparations
- RWAY
- Sector
- ATXS Health Care
- RWAY
- Exchange
- ATXS Nasdaq
- RWAY Nasdaq
- Market Cap
- ATXS 401.2M
- RWAY 395.5M
- IPO Year
- ATXS 2015
- RWAY 2021
- Fundamental
- Price
- ATXS $5.86
- RWAY $10.33
- Analyst Decision
- ATXS Strong Buy
- RWAY Buy
- Analyst Count
- ATXS 7
- RWAY 6
- Target Price
- ATXS $32.43
- RWAY $10.75
- AVG Volume (30 Days)
- ATXS 479.1K
- RWAY 287.6K
- Earning Date
- ATXS 08-11-2025
- RWAY 08-07-2025
- Dividend Yield
- ATXS N/A
- RWAY 11.63%
- EPS Growth
- ATXS N/A
- RWAY 51.80
- EPS
- ATXS N/A
- RWAY 1.67
- Revenue
- ATXS N/A
- RWAY $140,021,000.00
- Revenue This Year
- ATXS N/A
- RWAY N/A
- Revenue Next Year
- ATXS N/A
- RWAY N/A
- P/E Ratio
- ATXS N/A
- RWAY $6.19
- Revenue Growth
- ATXS N/A
- RWAY N/A
- 52 Week Low
- ATXS $3.56
- RWAY $8.35
- 52 Week High
- ATXS $12.92
- RWAY $12.09
- Technical
- Relative Strength Index (RSI)
- ATXS 62.16
- RWAY 65.64
- Support Level
- ATXS $5.43
- RWAY $9.95
- Resistance Level
- ATXS $5.97
- RWAY $10.22
- Average True Range (ATR)
- ATXS 0.44
- RWAY 0.17
- MACD
- ATXS 0.06
- RWAY 0.03
- Stochastic Oscillator
- ATXS 82.37
- RWAY 95.06
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
About RWAY Runway Growth Finance Corp.
Runway Growth Finance Corp is a specialty finance company focused on providing senior secured loans to high-growth-potential companies in technology, life sciences, healthcare information and services, business services, select consumer services and products, and other high-growth industries. The company has Investments in the United States, Germany, and Canada, with the majority of its portfolio invested in the United States.